Tarsa Therapeutics

Website:
http://tarsatherapeutics.com/

Phone:
267-273-7940

Address:
8 Penn Center, 1628 John F. Kennedy Boulevard, Suite 1400, Philadelphia, PA

Sector:

  • Private

Focus:

  • Biotechnology

Tarsa Therapeutics, Inc. was founded in 2009 with the goal of developing innovative therapies for the treatment and prevention of osteoporosis and related bone diseases. Tarsa is developing TBRIA™ an oral formulation of salmon calcitonin, which is a peptide hormone that inhibits bone resorption, a key process underlying the development of osteoporosis.

Our Sponsors